Literature DB >> 25535253

New TB treatments hiding in plain sight.

Andrew J Olive1, Christopher M Sassetti2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25535253      PMCID： PMC4328643          DOI： 10.15252/emmm.201404815

Source DB:  PubMed          Journal:  EMBO Mol Med        ISSN： 1757-4676            Impact factor:   12.137


× No keyword cloud information.
  11 in total

1.  WHO global tuberculosis control report 2010. Summary.

Authors: 
Journal:  Cent Eur J Public Health       Date:  2010-12       Impact factor: 1.163

Review 2.  Autophagy in human health and disease.

Authors:  Augustine M K Choi; Stefan W Ryter; Beth Levine
Journal:  N Engl J Med       Date:  2013-02-14       Impact factor: 91.245

Review 3.  Diabetes and immunity to tuberculosis.

Authors:  Nuria Martinez; Hardy Kornfeld
Journal:  Eur J Immunol       Date:  2014-02-16       Impact factor: 5.532

4.  Metformin as adjunct antituberculosis therapy.

Authors:  Amit Singhal; Liu Jie; Pavanish Kumar; Gan Suay Hong; Melvin Khee-Shing Leow; Bhairav Paleja; Liana Tsenova; Natalia Kurepina; Jinmiao Chen; Francesca Zolezzi; Barry Kreiswirth; Michael Poidinger; Cynthia Chee; Gilla Kaplan; Yee Tang Wang; Gennaro De Libero
Journal:  Sci Transl Med       Date:  2014-11-19       Impact factor: 17.956

5.  Autophagy protects against active tuberculosis by suppressing bacterial burden and inflammation.

Authors:  Eliseo F Castillo; Alexander Dekonenko; John Arko-Mensah; Michael A Mandell; Nicolas Dupont; Shanya Jiang; Monica Delgado-Vargas; Graham S Timmins; Dhruva Bhattacharya; Hongliang Yang; Julie Hutt; C Rick Lyons; Karen M Dobos; Vojo Deretic
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-23       Impact factor: 11.205

6.  Extracellular M. tuberculosis DNA targets bacteria for autophagy by activating the host DNA-sensing pathway.

Authors:  Robert O Watson; Paolo S Manzanillo; Jeffery S Cox
Journal:  Cell       Date:  2012-08-17       Impact factor: 41.582

Review 7.  In search of a new paradigm for protective immunity to TB.

Authors:  Cláudio Nunes-Alves; Matthew G Booty; Stephen M Carpenter; Pushpa Jayaraman; Alissa C Rothchild; Samuel M Behar
Journal:  Nat Rev Microbiol       Date:  2014-03-03       Impact factor: 60.633

8.  Functional drug screening reveals anticonvulsants as enhancers of mTOR-independent autophagic killing of Mycobacterium tuberculosis through inositol depletion.

Authors:  Mark Schiebler; Karen Brown; Krisztina Hegyi; Sandra M Newton; Maurizio Renna; Lucy Hepburn; Catherine Klapholz; Sarah Coulter; Andres Obregón-Henao; Marcela Henao Tamayo; Randall Basaraba; Beate Kampmann; Katherine M Henry; Joseph Burgon; Stephen A Renshaw; Angeleen Fleming; Robert R Kay; Karen E Anderson; Phillip T Hawkins; Diane J Ordway; David C Rubinsztein; Rodrigo Andres Floto
Journal:  EMBO Mol Med       Date:  2015-02       Impact factor: 12.137

9.  The ubiquitin ligase parkin mediates resistance to intracellular pathogens.

Authors:  Paolo S Manzanillo; Janelle S Ayres; Robert O Watson; Angela C Collins; Gianne Souza; Chris S Rae; David S Schneider; Ken Nakamura; Michael U Shiloh; Jeffery S Cox
Journal:  Nature       Date:  2013-09-04       Impact factor: 49.962

10.  New approaches to filling the gap in tuberculosis drug discovery.

Authors:  Martina Casenghi; Stewart T Cole; Carl F Nathan
Journal:  PLoS Med       Date:  2007-11-06       Impact factor: 11.069
View more
  1 in total

1.  Simvastatin Enhances the Immune Response Against Mycobacterium tuberculosis.

Authors:  Paola Del Carmen Guerra-De-Blas; Miriam Bobadilla-Del-Valle; Isabel Sada-Ovalle; Iris Estrada-García; Pedro Torres-González; Alejandro López-Saavedra; Silvia Guzmán-Beltrán; Alfredo Ponce-de-León; José Sifuentes-Osornio
Journal:  Front Microbiol       Date:  2019-09-20       Impact factor: 5.640
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.